Recent publications by Researchers affiliated with the Centre for Tropical Medicine and Global Health
Temporal correlations between RBD-ACE2 blocking and binding antibodies to SARS-CoV-2 variants in CoronaVac-vaccinated individuals and their persistence in COVID-19 patients.
Poolchanuan P. et al, (2025), Scientific reports, 15
Complement-mediated enhancement of SARS-CoV-2 antibody neutralisation potency in vaccinated individuals.
Mellors J. et al, (2025), Nature communications, 16
Identifying falsified COVID-19 vaccines by analysing vaccine vial label and excipient profiles using MALDI-ToF mass spectrometry
Arman BY. et al, (2025), npj Vaccines, 10
Asparagine availability controls germinal center B cell homeostasis
Yazicioglu YF. et al, (2024), Science Immunology, 9
Greater preservation of SARS-CoV-2 neutralising antibody responses following the ChAdOx1-S (AZD1222) vaccine compared with mRNA vaccines in haematopoietic cell transplant recipients.
Colton H. et al, (2024), British journal of haematology
COVID-19 vaccines are effective at preventing symptomatic and severe infection among healthcare workers: A clinical review
Galgut O. et al, (2024), Vaccine: X, 20
Immunogenicity of Abdala COVID-19 vaccine in Vietnamese people after primary and booster vaccinations: A prospective observational study in Vietnam
Thanh TT. et al, (2024), International Journal of Infectious Diseases, 147, 107173 - 107173
Obesity differs from diabetes mellitus in antibody and T-cell responses post-COVID-19 recovery
Ali M. et al, (2024), Clinical and Experimental Immunology, 218, 78 - 92
Global burden of bacterial antimicrobial resistance 1990–2021: a systematic analysis with forecasts to 2050
Naghavi M. et al, (2024), The Lancet, 404, 1199 - 1226
Starvation and infection: The role of sickness-associated anorexia in metabolic adaptation during acute infection
Jindal J. et al, (2024), Metabolism, 156035 - 156035
Anti-SARS-CoV-2 antibody dynamics after primary vaccination with two-dose inactivated whole-virus vaccine, heterologous mRNA-1273 vaccine booster, and Omicron breakthrough infection in Indonesian health care workers
Suwarti S. et al, (2024), BMC Infectious Diseases, 24
Concerted deletions eliminate a neutralizing supersite in SARS-CoV-2 BA.2.87.1 spike.
Duyvesteyn HME. et al, (2024), Structure (London, England : 1993)
Dysregulated immunologic landscape of the early host response in melioidosis.
Rongkard P. et al, (2024), JCI insight, 9
Global burden associated with 85 pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019.
IHME Pathogen Core Group None., (2024), The Lancet. Infectious diseases, 24, 868 - 895
Using matrix assisted laser desorption ionisation mass spectrometry combined with machine learning for vaccine authenticity screening.
Clarke R. et al, (2024), NPJ vaccines, 9
Diabetes and risk of hospitalisation due to infection in northeastern Thailand: Retrospective cohort study using population-based healthcare service data.
Peerawaranun P. et al, (2024), Diabetic medicine : a journal of the British Diabetic Association
Immunogenicity of COVID-19 vaccines in patients with follicular lymphoma receiving frontline chemoimmunotherapy.
Lim YJ. et al, (2024), British journal of haematology
Implications of suboptimal measles immunity in UK health-care workers.
Ho A. et al, (2024), Lancet (London, England)
A structure-function analysis shows SARS-CoV-2 BA.2.86 balances antibody escape and ACE2 affinity
Liu C. et al, (2024), Cell Reports Medicine, 5, 101553 - 101553